II. Indications
III. Physiology
- See Omega-3 Fatty Acid
- 
                          Omega-3 Fatty Acids are available as two different products (often combined)- Eicosapentaenoic Acid (EPA, icosapentaenoic acid)- May reduce Cardiovascular Risk
 
- Docosahexaenoic Acid (DHA, ethyl ester)- Reduces Triglycerides, but not shown to alter Cardiovascular Risk
 
 
- Eicosapentaenoic Acid (EPA, icosapentaenoic acid)
IV. Medications: Supplements (OTC)
- Supplement sources- Cod liver oil
- Standard fish body oil
- Omega-3 Fatty Acid concentrate
 
- Supplement Capsules (1 gram)- Eicosapentaenoic Acid (EPA, icosapentaenoic acid): 180 mg
- Docosahexaenoic Acid (DHA, ethyl ester): 120 mg
 
- Liquid- Variable concentrations per manufacturer
 
- Food sources for acquiring in diet
V. Medications: Prescriptions
- Lovaza- Contents (per 1 gram capsule)- EPA 465 mg
- DHA 375 mg
 
- Efficacy (4 gram/day dose)- Lowers Triglycerides 45%
- Risk of increased LDL Cholesterol
 
 
- Contents (per 1 gram capsule)
- Vascepa- Contents (per 1 gram capsule)- EPA 1000 mg
 
- Efficacy (4 gram/day dose)- Lowers Triglycerides 27%
 
 
- Contents (per 1 gram capsule)
- References- (2013) Presc Lett 20(1):1-2
- Ballantyne (2012) Am J Cardiol 110(7):984-92 [PubMed]
 
VI. Dosing
- Standard dosing: 1 gram capsule or equivalent liquid daily- Coronary Artery Disease Prevention
- Does not appear effective (at 1 g dose) for CAD primary prevention in those without CAD
 
- Higher dose: 2-4 grams per day- Hypertriglyceridemia
- Currently being researched as to benefits and risks
 
VII. Efficacy
VIII. Adverse Effects
- Well tolerated in most patients
- Fish after-taste
- Gastrointestinal upset
- Prolonged Bleeding Time
- Increased LDL Cholesterol
- Mercury Poisoning risk (depending on source of extract)
- 
                          Atrial Fibrillation
                          - Longterm Marine Omega 3 Fatty Acids (esp. >1 g/day) are associated with an increased risk of Atrial Fibrillation
- Mean study age >60 years old
- Hazard Ratio (HR) 1.25
- Gencer (2021) Circulation 144(25):1981-90 +PMID: 34612056 [PubMed]
 
IX. References
Images: Related links to external sites (from Bing)
Related Studies
| lovaza (on 12/2/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| LOVAZA 1 GM CAPSULE | Generic | $0.18 each | 
| vascepa (on 12/29/2021 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| VASCEPA 0.5 GM CAPSULE | $1.66 each | |
| VASCEPA 1 GM CAPSULE | Generic | $1.76 each | 
